1. SightScore (Seonix Bio) is a genetic risk-testing service for primary open-angle glaucoma.
2. It uses a saliva test to identify high-risk individuals and allows for earlier diagnosis and personalized treatment. The test also assesses low-risk individuals who may benefit from less frequent monitoring.
3. SightScore examines 7 million genetic variants in a patient's genome. 

Source: Ophthalmology Management